Duality Biotherapeutics Inc 2025 Sustainability Report
Company: Duality Biotherapeutics Inc
Sector: Manufacturing
Country: China
Year: 2025
Type: Sustainability Report
Pages: 75
The report describes DualityBio's 2025 listing and approximately RMB 1.852 billion in revenue, alongside a pipeline of 13 proprietary ADC candidates and 10 global clinical trials. It reports first-time Scope 3 accounting and 802.18 tCO2e of location-based Scope 2 emissions. Social highlights include 231 employees, 100% training coverage, 15 average training hours per employee, and zero work-related fatalities.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.